Caplin Point Laboratories Ltd. Financials: Quarterly Results
Revenue
564.41
Cr.
PAT
160.21
Cr.
EBITDA
201.14
Cr.
Caplin Point Laboratories Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 534.04 | 510.22 | 502.45 | 492.96 | 483.10 |
| Total Income From Operations (Cr.) | 534.04 | 510.22 | 502.45 | 492.96 | 483.10 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 201.14 | 184.61 | 176.76 | 177.45 | 168.77 |
| P/L Before Exceptional Items & Tax (Cr.) | 200.98 | 184.43 | 176.59 | 177.27 | 168.56 |
| P/L After Tax from Ordinary Activities (Cr.) | 160.21 | 150.73 | 145.20 | 140.08 | 130.91 |
| Net Profit/Loss For the Period (Cr.) | 160.21 | 150.73 | 145.20 | 140.08 | 130.91 |
| Basic EPS | 20.32 | 20.10 | 18.75 | 18.28 | 17.22 |
FAQs
Caplin Point Laboratories Ltd. announced its quarterly results for Q2 FY2026 on November 5, 2025.
In Q2 FY2026, Caplin Point Laboratories Ltd. are as follows:
Revenue: ₹564.41 crore
Net Profit: ₹160.21 crore.
For Q2 FY2026, Caplin Point Laboratories Ltd. posted ₹564.41 crore in revenue and ₹160.21 crore in net profit.
Past quarterly results for Caplin Point Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.